🇨🇦 Canada Wait: 18 wks vs 🇨🇳 Beijing: often days. Details →

Lymphoma: Treatment in Beijing

Key test: PET-CT + expert hematopathologyDiagnosis from $600
Medically reviewed by ChinaMedPass Medical TeamUpdated 1 cited sourceEditorial policy

Short answer

Lymphomas — cancers of the immune system — range from curable-with-chemo Hodgkin disease to indolent types best watched; everything follows from precise pathology subtyping. Beijing Cancer Hospital's lymphoma unit and Peking University People's Hematology Institute are national leaders, with PET-CT staging from about $600.

Overview

"Lymphoma" is dozens of diseases with opposite playbooks: aggressive types race to combination chemotherapy (often curative), indolent types may be monitored for years, and cellular therapies (CAR-T) now backstop relapsed disease. Subtype — read from tissue by expert hematopathologists — is destiny.

In Beijing

Beijing Cancer Hospital's lymphoma department is among China's most published and trial-active; Peking University People's Hospital hosts a world-renowned hematology institute (including transplant and CAR-T). Pathology re-review of your existing biopsy plus PET-CT staging typically completes within a week.

Typical costs

  • PET-CT staging: from about $600
  • Expert pathology re-review + written plan: from $400
  • Chemotherapy/CAR-T where indicated: individual quote — China's CAR-T pricing is a fraction of US costs

How we help

Send your records for a free assessment — we return a written plan and itemized quote, arrange the right specialist and interpreter, and coordinate everything on the ground.

Sources: Peking University People's Hospital — Institute of Hematology

Lymphoma in Beijing — hospitals, costs & next steps

Recommended hospitals

Beijing Cancer Hospital
Trial-leading lymphoma department
Peking University People's Hospital
World-renowned hematology institute — transplant & CAR-T

Departments

Hematology at Peking University People's Hospital
Home of the world-renowned Peking University Institute of Hematology — global leadership in haploidentical bone-marrow transplant, plus comprehensive leukemia, lymphoma and CAR-T care.

Treatments & procedures

PD-1 / PD-L1 Immunotherapy
PD-1/PD-L1 immunotherapy helps the immune system attack cancer and is now standard in many tumor types. China has approved multiple agents — including domestic ones priced 60–80% below Western list prices — available at Beijing's top cancer centers when biomarkers support their use.

How China MedPass helps

China Specialist Second Opinion Package
A written second opinion from a senior Beijing tertiary-hospital specialist on your existing scans and records — no travel required for the review itself.
DICOM Imaging & Pathology Review
Your scans and biopsy slides re-read by senior Beijing specialists — a written report on what the images and tissue actually show.

Guides & resources

Cancer Screening in China for Foreigners: PET-CT and Early Detection in Beijing
Why international patients consider cancer screening in China, what a Beijing screening package and PET-CT involve, who it suits, typical costs and how

Lymphoma — frequently asked questions

Why does lymphoma subtype matter so much?

＋

Because treatments diverge completely: aggressive B-cell lymphomas get immediate curative-intent chemo-immunotherapy, indolent ones are often watched, and T-cell or Hodgkin types follow different protocols again. An expert hematopathology re-review of your biopsy (from $400) is the foundation of every later decision.

Unsure about a diagnosis or treatment plan?

Send us your records — we arrange a written second opinion from a leading Beijing specialist, with certified translation, typically within days.

Get a free assessmentSecond opinion service →

Medical information on this page is general guidance, not a diagnosis. Always confirm with a qualified physician.

Get a Free Assessment →